UBS AM
NUVB icon

UBS AM’s Nuvation Bio NUVB Stock Holding History

UBS AM’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
509,871
-2,290
-0.4% -$11.2K ﹤0.01% 1896
2026
Q1 		$2.2M Sell
512,161
-8,877
-2% -$49.5K ﹤0.01% 2004
2025
Q4 		$4.67M Buy
521,038
+150,177
+40% +$930K ﹤0.01% 1498
2025
Q3 		$1.37M Sell
370,861
-318,994
-46% -$869K ﹤0.01% 1895
2025
Q2 		$1.35M Buy
689,855
+253,938
+58% +$529K ﹤0.01% 2308
2025
Q1 		$767K Buy
435,917
+88,111
+25% +$201K ﹤0.01% 2406
2024
Q4 		$925K Buy
347,806
+122,187
+54% +$315K ﹤0.01% 2397
2024
Q3 		$517K Sell
225,619
-8,670
-4% -$26.4K ﹤0.01% 2636
2024
Q2 		$684K Buy
+234,289
New +$715K ﹤0.01% 2542
2023
Q4 		– Sell
-178,816
Closed -$240K – 2584
2023
Q3 		$240K Hold
178,816
– – ﹤0.01% 2477
2023
Q2 		$297K Hold
178,816
– – ﹤0.01% 2481
2023
Q1 		$297K Buy
178,816
+32,226
+22% +$65.3K ﹤0.01% 2481
2022
Q4 		$281K Buy
146,590
+4,216
+3% +$8.53K ﹤0.01% 2351
2022
Q3 		$319K Sell
142,374
-16,838
-11% -$48.1K ﹤0.01% 2481
2022
Q2 		$516K Buy
159,212
+28,996
+22% +$126K ﹤0.01% 2300
2022
Q1 		$685K Hold
130,216
– – ﹤0.01% 2331
2021
Q4 		$1.11M Buy
130,216
+41,231
+46% +$379K ﹤0.01% 2160
2021
Q3 		$885K Hold
88,985
– – ﹤0.01% 2230
2021
Q2 		$828K Buy
+88,985
New +$1.01M ﹤0.01% 2316

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

UBS AM's NUVB Position: Q2 2026 in Review

UBS AM reduced its Nuvation Bio (NUVB) stake by 0.45% in Q2 2026, selling an estimated $11.2K and leaving 509,871 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1896.

UBS AM first reported a position in NUVB in Q2 2021 and has held it in 19 quarters since. The position peaked at $4.67M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • UBS AM held 509,871 shares of Nuvation Bio worth $2.9M as of Q2 2026.
  • UBS AM sold 2,290 Nuvation Bio shares in Q2 2026, an estimated $11.2K.
  • Nuvation Bio made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1896 holding.
  • UBS AM first reported a position in Nuvation Bio in Q2 2021 and has held it in 19 quarters since.
  • UBS AM's Nuvation Bio position peaked at $4.67M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.